Marpai, Inc. (MRAI) Stock Price & Analysis
Marpai, Inc. (MRAI) fell 5.36% to USD 0.53 as of June 10, 2026 at 03:44 UTC, according to Nexqual real-time market data.
MRAI last closed at USD 0.56; the session ranged USD 0.52–0.53 on volume of 192 shares. Market capitalization is $13.41M, with a 52-week range of USD 0.22–1.78 (OQX). Source: Nexqual, June 10, 2026 at 03:44 UTC.
Key Statistics (as of June 10, 2026 at 03:44 UTC)
| Price | USD 0.53 |
|---|---|
| Change | ▼ 5.36% (down) |
| Previous Close | USD 0.56 |
| Open | USD 0.52 |
| Day Range | USD 0.52 – 0.53 |
| 52-Week Range | USD 0.22 – 1.78 |
| Volume | 192 shares |
| Market Cap | $13.41M |
| Exchange | OQX |
Technical Analysis (MRAI)
Nexqual's technical model rates MRAI "STRONG BUY" based on 5 bullish and 0 bearish signals across 124 daily candles, as of June 10, 2026 at 03:44 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 57.19 (neutral) |
| vs SMA50 | Above (USD 0.35) |
| MACD | 0.08 (positive) |
Analyst Ratings (MRAI)
Wall Street analysts rate MRAI "None", per Nexqual as of June 10, 2026 at 03:44 UTC.
| Consensus Rating | None |
|---|
Earnings (MRAI)
| Next Earnings Date | 2026-08-12 |
|---|
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2024-03-31 | USD -0.46 vs est -0.43 ▼ miss |
| 2023-12-31 | USD -0.09 vs est -0.19 ▲ beat |
| 2023-09-30 | USD -0.97 vs est -0.79 ▼ miss |
| 2023-06-30 | USD -1.05 vs est -0.95 ▼ miss |
Source: Nexqual, June 10, 2026 at 03:44 UTC.
Financials & Fundamentals (MRAI)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
Source: Nexqual, June 10, 2026 at 03:44 UTC.
Financial Health Score (MRAI)
Nexqual rates Marpai, Inc.'s overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 03:44 UTC.
| Growth | Strong — Revenue +53% YoY (annual) |
|---|---|
| Profitability | Weak — Small revenue base — building scale |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Ownership (MRAI)
| Insider Ownership | +51.23% |
|---|---|
| Institutional Ownership | +4.07% |
| Shares Outstanding | 25.29M |
| Short % of Float | +0.24% |
Source: Nexqual, June 10, 2026 at 03:44 UTC.
Leadership (MRAI)
Marpai, Inc. is led by Damien Francis Lamendola (age 69), President, CEO & Director, per Nexqual as of June 10, 2026 at 03:44 UTC.
| President, CEO & Director | Damien Francis Lamendola (age 69) |
|---|---|
| CFO & Company Secretary | Steve Johnson (age 54) |
| Co-Founder & Independent Chairman of the Board | Yaron I. Eitan (age 69) |
| Chief Strategy Officer | Richard Brewer |
| President of MarpaiRx | Mimi Davis |
Major Backers & Investors (MRAI)
Notable institutional backers of Marpai, Inc. include FNY Investment Advisers, LLC, according to Nexqual as of June 10, 2026 at 03:44 UTC.
Active Investors
| Investor | Stake |
|---|---|
| FNY Investment Advisers, LLC | 0.14% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 0.88% |
Source: Nexqual, June 10, 2026 at 03:44 UTC.
From Marpai, Inc.'s Latest SEC 10-K Filing (filed 2026-03-25)
Key Strengths & Strategy (as disclosed to the SEC)
- Marpai, Inc., together with its subsidiaries, operates as a technology-driven healthcare payer company in the United States.
- The company provides third-party administrator and value-oriented health plan services to employers that directly pay for employee health benefits.
- It also offers in-house ancillary services that include clinical care management, a nurse-led guide for at-risk members across the care continuum; repricing insights, which are out-of-network claims; Marpai PACCS, a pharmacy advocacy cost containment solution that is a member-driven pharmacy savings program; and MarpaiRx, a national pharmacy benefit management program.
- In addition, the company provides health plan administration services, third-party vendor services, and complementary services, such as case management, actuarial, and bill review services.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CNTX | Context Therapeutics Inc. | USD 1.52 | ▼ 13.14% |
| PXMD | PaxMedica, Inc. | USD 0 | ▲ 0% |
| SMFL | Smart for Life, Inc. | USD 0 | ▲ 0% |
| STRN | SMART Trend 25 ETF | USD 26.94 | ▼ 1.04% |
| SNTG | Sentage Holdings Inc. | USD 2.21 | ▼ 7.14% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:44 UTC. This page is informational and not investment advice.